Showing results (151-160 of 370) with videos related to
Sort By:
Pageof 37
Presse Medicale (Paris, France : 1983)|June 19, 2007
[Contact dermatitis caused by acetazolamide under occlusion]Amélie Daveluy, Thierry Vial, Laurine Marty, et al.Therapie|December 20, 2024
Shaping the future of pharmacoepidemiology in France: Recommendations from the SFPT Pharmacoepidemiology Working GroupThomas Soeiro, Marion Allouchery, Johana Bene, et al.Neurosurgery|August 4, 2010
Endoscopic endonasal minimal access approach to the clivus: case series and technical nuancesJustin F Fraser, Gurston G Nyquist, Nicholas Moore, et al.Journal of Analytical Toxicology|June 9, 2007
Quantification of tricyclic antidepressants and monoamine oxidase inhibitors by high-performance liquid chromatography-tandem mass spectrometry in whole bloodKarine Titier, Nadège Castaing, Maité Le-Déodic, et al.International Journal of Surgical Pathology|October 12, 2019
Mycobacterium Spindle Cell Pseudotumor Caused by Mycobacterium xenopi: A First Described Association of a Rare Entity Presenting in the LungKarina Furlan, Prih Rohra, Fatima Mir, et al.Current Medical Research and Opinion|March 31, 2022
The CLARION study design and status update: a long-term, registry-based study evaluating adverse events of special interest in patients with relapsing multiple sclerosis newly started on cladribine tabletsHelmut Butzkueven, Nicholas Moore, Aida Aydemir, et al.Pharmacoepidemiology and Drug Safety|May 30, 2008
Prevalence of cholinesterase inhibitors in subjects with dementia in EuropeAntoine Pariente, Catherine Helmer, Yvon Merliere, et al.Schizophrenia Research|September 12, 2002
Neuroleptics and mortality in schizophrenia: prospective analysis of deaths in a French cohort of schizophrenic patientsChristine Montout, Francoise Casadebaig, Rajaa Lagnaoui, et al.Pharmacoepidemiology and Drug Safety|August 17, 2018
Risk of hospital admission for liver injury in users of NSAIDs and nonoverdose paracetamol: Preliminary results from the EPIHAM studySinem Ezgi Gulmez, Ulku Sur Unal, Régis Lassalle, et al.Cardiovascular Drugs and Therapy|April 30, 2004
Fluvastatin reduces cardiac mortality in patients with coronary heart diseaseChristie M Ballantyne, Günter Riegger, Nicholas Moore, et al.Pageof 37